Pathogenesis of gastrinomas associated with multiple endocrine neoplasia type 1
- PMID: 17440178
- PMCID: PMC1942163
- DOI: 10.1136/gut.2006.113985
Pathogenesis of gastrinomas associated with multiple endocrine neoplasia type 1
Abstract
Deletion of the second allele of the tumour suppressor gene MEN1 is assoiated with development of duodenal gastrin‐secreting microtumours in MEN1
Conflict of interest statement
Competing interests: None.
Comment on
-
Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions.Gut. 2007 May;56(5):637-44. doi: 10.1136/gut.2006.108910. Epub 2006 Nov 29. Gut. 2007. PMID: 17135306 Free PMC article.
References
-
- Jensen R T. Gastrinomas: advances in diagnosis and management. Neuroendocrinology 200480(Suppl 1)23–27. - PubMed
-
- Campana D, Piscitelli L, Mazzotta E.et al Zollinger–Ellison syndrome. Diagnosis and therapy. Minerva Med 200596187–206. - PubMed
-
- Gibril F, Jensen R T. Zollinger–Ellison syndrome revisited: diagnosis, biologic markers, associated inherited disorders, and acid hypersecretion. Curr Gastroenterol Rep 20046454–463. - PubMed
-
- Brandi M L, Gagel R F, Angeli A.et al Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001865658–5671. - PubMed
-
- Doherty G M. Multiple endocrine neoplasia type 1. J Surg Oncol 200589143–150. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical